side effects of glp-1 agonists Peptide/GLP-1 Complications: 11 Hidden Risks and You Must Know glp 1 indigestion Full article:

There have also been documented local skin reactions when using GLP-1 RAs, particularly with the long-acting formulations

Tirzepatide is the first dual agonist which has been approved for chronic weight management, but numerous other dual and/or triple agonists (cagrisema, retatrutide, mazdutide and survodutide) are also in phase 3 trials as potential treatments for obesity and its metabolic complications

For example, in head-to-head discussions, analysts have noted that Mounjaros weight-loss results slightly outperformed Wegovys in comparable trials

With less weight to carry, women with lipedema often experience improved mobility and reduced discomfort during physical activities

GLP-1RAs suppress hyperglycemia-induced proliferation, migration and apoptosis of VSMCs via suppressing the ERK1/2 and PI3K/Akt pathways [10]

Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice